Velvet Rx Tirzepatide Review: Cost, Three Public SKUs & Honest Verdict (2026)

Velvet Rx is a cash-pay telehealth platform publishing pricing across three public SKUs — semaglutide, tirzepatide, and an oral GLP-1 — uncommon transparency in compounded telehealth, though no legal entity, LegitScript badge, or compounding pharmacy is named anywhere. Every fact here comes from the company's own published program.

Three publicly priced SKUs

Worth highlighting directly: Velvet Rx publishes prices across three SKUs — semaglutide ($299), tirzepatide ($359), and oral GLP-1 ($349) — with first-month promo pricing shown upfront ($139/$199/$189). This is more pricing transparency than many compounded competitors offer.

What Velvet Rx is

Velvet Rx (velvetrx.com) is a cash-pay telehealth platform, offering compounded semaglutide, compounded tirzepatide, and an oral GLP-1 across three publicly-listed SKUs. A single monthly price includes the consult, prescription, 4 weeks of medication, and free 1-2 day shipping.

What Velvet Rx costs

First-month promo pricing runs $139 for semaglutide, $199 for tirzepatide, and $189 for the oral GLP-1; standing rates are $299/$359/$349 respectively.

An unnamed oral GLP-1 — a real gap

Worth flagging directly is the oral GLP-1 SKU doesn't name the specific drug — a real gap given that Rybelsus, Foundayo, and compounded oral semaglutide differ clinically. Confirm exactly what you're being prescribed before ordering.

The brand-vs-compounded question

Velvet Rx dispenses compounded semaglutide and tirzepatide, plus an unnamed oral GLP-1. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

Velvet Rx's real strengths: public pricing across three SKUs — uncommon in this category, first-month promo pricing shown upfront alongside standing rates, a single all-in monthly price, and FSA/HSA eligibility. The trade-offs are significant: the oral GLP-1 SKU doesn't name the specific drug, no LegitScript or NABP.pharmacy seal is displayed, no legal entity name is disclosed, no physical address is disclosed, and the compounding pharmacy partner isn't named. As with any GLP-1 program, and especially one this thin on corporate and pharmacy disclosure, ask directly which specific drug the oral SKU contains before ordering; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Velvet Rx's public pricing across three SKUs is a genuine transparency positive, but the unnamed oral drug, missing legal entity, and absent LegitScript badge are real gaps worth asking about directly. For a provider with fuller corporate and pharmacy disclosure, compare it against Tyde Wellness or Ondra Health. For a provider with a similarly self-hosted accreditation badge, see WePeptideRx. See our best tirzepatide providers ranking for the full field.